Device Trial Radar · NCT04203810
Effectiveness and Tolerability of Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
194
Actual
Start
Jan 14, 2020
Primary completion
Dec 4, 2020
Study completion Dec 4, 2020
Sponsor
- Lead sponsor
- Bitop AGNot on our public-company list
- Sponsor type
- Industry
- First posted
- Dec 18, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The aim of this multicentre, actively controlled, randomized, open label, parallel group, prospective, comparator study is to collect data on the clinical effectiveness and tolerability of the medical device ERS09 compared to a well-established comparator spray in the symptomatic treatment of sore throat due to acute pharyngitis and dry cough.
Conditions
- Sore Throat
- Acute Pharyngitis
- Cough
Interventions
Ectoin® Mouth and Throat Spray Althaea Honey (ERS09)Device
4 puffs to be administered as needed several times a day for patients aged ≥ 12 years. A maximum of 10 applications per day should not be exceeded.
EMSER® Hals-und Rachenspray (throat spray)Device
1 to 3 puffs to be administered several times a day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of mean total symptom scoreTime frame: 7 days
- Change of daily symptom scoreTime frame: 1 day
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Dr. Pasch
Aachen, Germany
Dr. Sondermann
Aachen, Germany
Dr. Männer
Arnsberg, Germany
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.